Research Article

Validation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group Neurotoxicity Questionnaire for the Latin American Population

Table 4

Comparison of peripheral neuropathy according to cancer type ().

BreastColorectalHematologicGastricGynaecologicalOther

Physical well-being, PWB (0–28)21.9 (5.7)21.0 (5.0)17.5 (5.2)21.0 (4.7)11.3 (12.3)20. 7 (6.7)
Social/family well-being, SWB (0–28)20.5 (5.6)16.9 (6.8)16.8 (6.2)29.6 (6.2)20.0 (4.0)19.8 (7.4)
Emotional well-being, EWB (0–24)17.6 (3.8)17.7 (4.6)15.6 (3.9)20.4 (4.9)11.3 (4.0)17.9 (5.6)
Functional well-being, FWB (0–28)21.6 (3.5)17.9 (6.4)15.7 (6.1)20.0 (7.2)16.7 (7.1)18.8 (3.8)
Neurotoxicity, NtxS (0–44)32.0 (8.1)30.3 (8.6)29.1 (7.4)32.3 (5.3)27.7 (13.4)33.4 (6.3)
FACT/GOG-Ntx total score (0–152)113.8 (18.5)103.9 (25.6)94.7 (21.3)114.3 (21.3)87.0 (35.3)110.6 (24.3)
FACT-G total score (0–108)81.8 (12.4)73.5 (19.5)65.6 (16.2)82.0 (17.2)59.3 (21.9)77.1 (18.6)
FACT/GOG-Ntx TOI (0–100)75.6 (13.7)69.2 (17.1)62.3 (15.0)73.3 (12.3)55.7 (30.7)72.9 (14.4)

Abbreviations: . . Values are expressed as mean (standard deviation).